Immediate Impact

1 by Nobel laureates 60 standout
Sub-graph 1 of 24

Citing Papers

Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
2 intermediate papers

Works of F. Di Perna being referenced

Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone
2009
Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease
2002

Author Peers

Author Last Decade Papers Cites
F. Di Perna 455 387 30 37 21 517
Hylan A. Bickerman 452 177 38 23 26 608
Sundeep Salvi 378 296 34 37 26 516
Irving H. Itkin 353 454 55 9 17 624
Peter Bremner 434 345 18 52 18 629
I P Williams 291 183 14 49 25 464
G. L. Brinkman 176 124 50 21 22 618
A.J. Avery 384 289 25 8 15 552
N Lindholm 204 333 18 16 17 532
Nick Adams 471 482 12 12 20 594
B. J. Duffy 185 137 66 12 22 584

All Works

Loading papers...

Rankless by CCL
2026